Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Joe Yujiao Chang, Suresh Senan, M.A. Paul et al. · The Lancet Oncology · 2015
Cited by 1,462 works. doi:10.1016/s1470-2045(15)70168-3
Authors
- Joe Yujiao Chang
- Suresh Senan
- M.A. Paul
- Reza John Mehran
- Alexander V. Louie
- Peter A. Balter
- Harry J.M. Groen
- Stephen E. McRae
- Joachim Widder
- Lei Feng
- Ben E.E.M. van den Borne
- Mark F. Munsell
- Coen Hurkmans
- Donald A. Berry
- Erik D. van Werkhoven
- John J. Kresl
- Anne‐Marie C. Dingemans
- Cornelis J.A. Haasbeek
- Larry Steven Carpenter
References
- Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
- Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial
- Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma
- Data from The Society of Thoracic Surgeons General Thoracic Surgery database: The surgical management of primary lung tumors
- Surgery for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review of the Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Approaches to Lobectomy
- Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer
- Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non–Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery?
- Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis
- Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403